{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:36:54Z","timestamp":1772757414983,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:p>White coat hypertension is considered to be a benign condition that does not require antihypertensive treatment. Ambulatory blood pressure (ABP) was measured in 284 participants in the Hypertension in the Very Elderly Trial (HYVET), a double-blind randomized trial of indapamide sustained release 1.5 mg\u00b1perindopril 2 to 4 mg versus matching placebo in hypertensive subjects (systolic blood pressure 160\u2013199 mm Hg) aged &gt;80 years. ABP recordings (Diasys Integra II) were obtained in 112 participants at baseline and 186 after an average follow-up of 13 months. At baseline, clinic blood pressure (CBP) exceeded the morning ABP by 32\/10 mm Hg. Fifty percent of participants fulfilled the established criteria for white coat hypertension. The highest ABP readings were in the morning (average 140\/80 mm Hg), the average night-time pressure was low at 124\/72 mm Hg, and the average 24-hour blood pressure was 133\/77 mm Hg. During follow-up, the systolic\/diastolic blood pressure placebo-active differences averaged 6\/5 mm Hg for morning ABP, 8\/5 mm Hg for 24-hour ABP, and 13\/5 mm Hg for CBP. The lowering of blood pressure over 24 hours supports the reduction in blood pressure with indapamide sustained release\u00b1perindopril as the explanation for the reduction in total mortality and cardiovascular events observed in the main HYVET study. Because we estimate that 50% had white coat hypertension in the main study, this condition may benefit from treatment in the very elderly.<\/jats:p>","DOI":"10.1161\/hypertensionaha.112.191791","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T06:45:46Z","timestamp":1353393946000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":66,"title":["Does White Coat Hypertension Require Treatment Over Age 80?"],"prefix":"10.1161","volume":"61","author":[{"given":"Christopher J.","family":"Bulpitt","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Beckett","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Peters","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A.","family":"Staessen","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Guang","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Comsa","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Fagard","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Dumitrascu","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesselka","family":"Gergova","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta L.","family":"Antikainen","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Cheek","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakravarthi","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Imperial College London, London, United Kingdom (C.J.B., N.B., R.P., R.L.A.); Brighton and Sussex Medical School, Brighton, United Kingdom (C.J.B., C.R.); Department of Cardiology, University of Leuven, Leuven, Belgium (J.A.S., R.H.F.); Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, China (J.-G.W.); Strada Narciselor, Fagaras, Romania (M.C.); Spitalul Judetean Cluj, Clinica Medicala 2, Cluj, Romania (D.D...."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07186-0"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.099502"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116518"},{"key":"e_1_3_3_6_2","first-page":"729","article-title":"White coat effect in treated hypertensive patients: sex differences.","volume":"9","author":"Myers MG","year":"1995","unstructured":"Myers MG, Reeves RA. White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens. 1995;9:729\u2013733.","journal-title":"J Hum Hypertens"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.10.1139"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbp.0000184965.30220.10"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200118030-00001"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801369"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00153-3"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7285.531"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/7.3.228"},{"key":"e_1_3_3_14_2","first-page":"319","article-title":"Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.","volume":"4","author":"Staessen JA","year":"1999","unstructured":"Staessen JA, Beilin L, Parati G, Waeber B, White W. Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit. 1999;4:319\u2013331.","journal-title":"Blood Press Monit"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200112000-00016"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2008.07681.x"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.106.662254"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200302000-00008"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afm193"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2007.43"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f3150b"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200412000-00007"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.111.180653"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02987-4"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc3201.094227"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.6.539"},{"key":"e_1_3_3_27_2","first-page":"307","article-title":"Assessment of antihypertensive efficacy by non-invasive ambulatory blood pressure monitoring.","volume":"1","author":"Asmar R","year":"1996","unstructured":"Asmar R, Waeber B. Assessment of antihypertensive efficacy by non-invasive ambulatory blood pressure monitoring. Blood Press Monit. 1996;1:307.","journal-title":"Blood Press Monit"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001772"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.05696.x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.100727"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBP.0b013e3282411a12"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6687.1552"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61538-4"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200506000-00003"},{"key":"e_1_3_3_35_2","article-title":"Clinical management of primary hypertension in adults (update).","author":"National Institute for Health and Clinical Excellence","year":"2011","unstructured":"National Institute for Health and Clinical Excellence. Clinical management of primary hypertension in adults (update). (Clinical Guideline. 127) 2011. http:\/\/guidance.nice.org.uk\/CG127. Accessed September 22, 2011.","journal-title":"(Clinical Guideline. 127)"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282ef6185"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3281c49da5"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.112.191791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:57:57Z","timestamp":1715590677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.112.191791"}},"subtitle":["Results of the Hypertension in the Very Elderly Trial Ambulatory Blood Pressure Side Project"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.112.191791"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.112.191791","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"2012-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-10-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}